RARE CARE Trademark

Trademark Overview

On Thursday, December 12, 2013, a trademark application was filed for RARE CARE with the United States Patent and Trademark Office. The USPTO has given the RARE CARE trademark a serial number of 79145362. The federal status of this trademark filing is IR CANCELLED - US REGISTRATION CANCELLED as of Monday, December 11, 2023. This trademark is owned by SIGMA-TAU; INDUSTRIE FARMACEUTICHE RIUNITE S.p.A.. The RARE CARE trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system including diabetes and metabolic diseases, the respiratory system, the musculoskeletal system, and the genitourinary system, for the treatment of inflammatory disorders, for use in hematology, in oncology, in tissue and organ transplantation, and in ophthalmology, for prevention and treatment gastroenterological disorders, and for the prevention and treatment of ocular disorders or diseases; anti-infectives; pharmaceutical preparations treating bacterial-based disease; antivirals; anti-biotics; antifungal preparations; vaccines
rare care

General Information

Serial Number79145362
Word MarkRARE CARE
Filing DateThursday, December 12, 2013
Status404 - IR CANCELLED - US REGISTRATION CANCELLED
Status DateMonday, December 11, 2023
Registration Number4705806
Registration DateTuesday, March 24, 2015
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, January 6, 2015

Trademark Statements

Description of MarkThe mark consists of the stylized wording "RARE" appearing backwards over the stylized wording "CARE" on a rectangular background.
Goods and ServicesPharmaceutical preparations for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system including diabetes and metabolic diseases, the respiratory system, the musculoskeletal system, and the genitourinary system, for the treatment of inflammatory disorders, for use in hematology, in oncology, in tissue and organ transplantation, and in ophthalmology, for prevention and treatment gastroenterological disorders, and for the prevention and treatment of ocular disorders or diseases; anti-infectives; pharmaceutical preparations treating bacterial-based disease; antivirals; anti-biotics; antifungal preparations; vaccines
Indication of Colors claimedColor is not claimed as a feature of the mark.
NOT AVAILABLE"CARE"

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, November 26, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameALFASIGMA S.P.A.
Party Type31 - New Owner After Registration
Legal Entity Type99 - Other
AddressIT
Party NameSIGMA-TAU; INDUSTRIE FARMACEUTICHE RIUNITE S.p.A.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressIT
Party NameSIGMA-TAU; INDUSTRIE FARMACEUTICHE RIUNITE S.p.A.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressIT
Party NameSIGMA-TAU; INDUSTRIE FARMACEUTICHE RIUNITE S.p.A.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressIT

Trademark Events

Event DateEvent Description
Saturday, April 26, 2014NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Thursday, April 17, 2014SN ASSIGNED FOR SECT 66A APPL FROM IB
Friday, April 18, 2014NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, April 18, 2014ASSIGNED TO EXAMINER
Tuesday, April 22, 2014APPLICATION FILING RECEIPT MAILED
Friday, April 25, 2014NON-FINAL ACTION WRITTEN
Wednesday, November 12, 2014TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, April 28, 2014REFUSAL PROCESSED BY MPU
Thursday, May 1, 2014NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Friday, May 16, 2014REFUSAL PROCESSED BY IB
Monday, November 10, 2014TEAS PETITION TO REVIVE RECEIVED
Monday, November 10, 2014PETITION TO REVIVE-GRANTED
Monday, November 10, 2014TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, November 11, 2014NOTICE OF REVIVAL - MAILED
Wednesday, November 12, 2014ASSIGNED TO LIE
Wednesday, November 12, 2014CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, December 4, 2014EXAMINER'S AMENDMENT ENTERED
Thursday, December 4, 2014EXAMINERS AMENDMENT -WRITTEN
Thursday, December 4, 2014EXAMINERS AMENDMENT E-MAILED
Thursday, December 4, 2014NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, December 4, 2014APPROVED FOR PUB - PRINCIPAL REGISTER
Saturday, January 3, 2015NOTIFICATION PROCESSED BY IB
Thursday, December 4, 2014LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, December 17, 2014NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, December 17, 2014NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, December 17, 2014NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Tuesday, March 24, 2020COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Tuesday, January 6, 2015PUBLISHED FOR OPPOSITION
Tuesday, January 6, 2015OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 24, 2015REGISTERED-PRINCIPAL REGISTER
Wednesday, June 24, 2015FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Friday, July 31, 2015FINAL DISPOSITION PROCESSED
Friday, July 31, 2015FINAL DISPOSITION NOTICE SENT TO IB
Friday, August 21, 2015FINAL DECISION TRANSACTION PROCESSED BY IB
Thursday, February 1, 2018CHANGE OF OWNER RECEIVED FROM IB
Friday, August 24, 2018CHANGE OF NAME/ADDRESS REC'D FROM IB
Tuesday, July 26, 2022TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Sunday, October 2, 2022TOTAL INVALIDATION PROCESSED BY THE IB
Monday, July 8, 2024DEATH OF INTERNATIONAL REGISTRATION
Monday, July 8, 2024NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Friday, September 9, 2022TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Friday, November 26, 2021CANCELLED SECTION 71
Friday, September 9, 2022INVALIDATION PROCESSED

Related Keywords

care rare system disorders treatment preparations prevention pharmaceutical anti diseases treating infectives